Poly Medicure Limited (POLYMED) — Announcement | 10 August 2026(2 announcements)

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement Neutral 📄 PDF
📢 Key Event
Audio recording of earnings call released
💡 Investor Takeaway
Shareholders can access the call audio to review the latest financial discussion.

Poly Medicure Limited announced that an audio recording of its earnings conference call for the quarter ended June 30, 2026, held on August 10, 2026, is now available on its website for investor reference.

2 Announcement Neutral 📄 PDF
📢 Key Event
CRISIL Monitoring Agency Report confirms QIP proceeds utilization compliance
🔄 What Changed
Net proceeds revised from Rs 98,499.98 lakh to Rs 98,534.37 lakh due to lower issue expenses
🔮 What's Next
No future deadlines or statements provided
💡 Investor Takeaway
Shareholders can view this as confirmation of disciplined capital allocation with no misuse of QIP funds.

Poly Medicure Limited disclosed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming compliance with utilization of Qualified Institutional Placement proceeds. The report, issued by CRISIL Ratings Limited, verifies that all proceeds were used as per the offer document for capital expenditure, inorganic initiatives, and general corporate purposes, with no deviations or conflicts of interest noted. The filing includes statutory auditor certification and management undertakings, reinforcing transparency in fund deployment.

About Poly Medicure Limited (POLYMED)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹15,192.77 Cr P/E: 46.4

View full POLYMED stock details →

📡 Get AI alerts when POLYMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track POLYMED — Free

📊 More POLYMED filings

See all POLYMED filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when POLYMED files new disclosures

Track POLYMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track POLYMED — Free

Free account · 2 AI queries/day